Abstract

Background and Objectives: Saffron treatment and photobiomodulation (PBM) are non-invasive therapeutic approaches able to mitigate and stabilize retinal degenerative diseases such as age-related macular degeneration (AMD). Although different, these therapies partially match their modulated pattern of genes. Recent attempts to find an additive effect by coadministration of saffron and PBM have failed. Instead, in this study, a different protocol to increase neuroprotection by providing consecutive saffron and PBM treatment administration is suggested. Materials and Methods: Albino rats, whose retinal damage was caused by light exposure (LD, light damage), were subjected to differential treatment protocols before and after LD: (1) PBM followed by saffron; and (2) single treatments of PBM. Thinning of the photoreceptor layer and neuro-inflammatory markers for gliosis and microglia were assessed via immune-histochemical techniques. Results: Results confirm that PBM and saffron alone cope with retinal neurodegenerative processes, preserving retinal thickness and gliosis and microglia invasion in a differential way. However, the synergistic effect of the combined treatment was restricted to the early neuroinflammation, even when provided sequentially. Conclusion: The broad spectra of action of both neuroprotectants require further investigation to identify other key pathways helpful in enhancing the effects of these two approaches in combination.

Highlights

  • IntroductionAge-related macular degeneration (AMD) is a multifactorial retinal neurodegenerative disease in which aging, genetic polymorphisms, and environmental factors lead to an irreversible lack of visual perception by activating neuro-inflammatory and neurodegenerative processes [1]

  • Materials and Methods: Albino rats, whose retinal damage was caused by light exposure (LD, light damage), were subjected to differential treatment protocols before and after LD: (1) PBM followed by saffron; and (2) single treatments of PBM

  • Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

Read more

Summary

Introduction

Age-related macular degeneration (AMD) is a multifactorial retinal neurodegenerative disease in which aging, genetic polymorphisms, and environmental factors lead to an irreversible lack of visual perception by activating neuro-inflammatory and neurodegenerative processes [1]. Photobiomodulation (PBM) offers a suitable approach to treat retinal neurodegeneration This non-invasive therapy consists of a 670 nm light treatment to enhance cytochrome. Saffron treatment and photobiomodulation (PBM) are noninvasive therapeutic approaches able to mitigate and stabilize retinal degenerative diseases such as age-related macular degeneration (AMD). Different, these therapies partially match their modulated pattern of genes.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call